Press Release Forum [] Forum Index

Press Release Forum []
Free Press Release Distribution

A site of EPR Network

 FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   RegisterRegister 
 ProfileProfile   Log in to check your private messagesLog in to check your private messages   Log inLog in 

Real Time Press Release Distribution is here. Try it out, it's free!


AnaSpec Introduces Agr D1 & D2 Thiolactone GO™ Peptides

Post new topic   Reply to topic    Press Release Forum [] Forum Index -> Biotech Press Releases
View previous topic :: View next topic  
Author Message

Joined: 15 Aug 2006
Posts: 238
Location: 34801 Campus Drive, Fremont, CA 94555

PostPosted: Thu Nov 12, 2009 1:49 pm    Post subject: AnaSpec Introduces Agr D1 & D2 Thiolactone GO™ Peptides Reply with quote

Fremont, CA – November 12, 2009

AnaSpec has announced the release of two structurally complex peptides, Agr D1 Thiolactone and Agr D2 Thiolactone, as part of its GO™ (catalog) peptides offering.

In Gram-positive bacteria, such as in Staphylococcus aureus, physiological changes in the bacterial population are dependent on specific cell densities and growth phases (known as quorum sensing). S. aureus specifically uses quorum sensing to control the expression of exoproteins implicated in virulence through the Agr (accessory gene regulator) locus. The Agr system is activated by an accumulation of extracellular mature peptide signals known as autoinducing peptides (AIPs). S. aureus has four distinct Agr groups, which exhibit bacterial interference. Each Agr group synthesizes a discrete AIP sequence. All four AIP sequences are composed of seven to nine amino acids and have a thiolactone ring in the C-terminal five residues through a cysteine side chain.

AnaSpec’s chemists have synthesized and purified these peptides, which contain an intramolecular thiol ester linkage between the Cys (5th amino acid from the C-terminus) and the C-terminal amino acid. Mass spectrometry and HPLC were used to confirm the molecular weight and purity (>95%) of these peptides.


1. P. McDowell, et al. Molecular Microbiology, 41, 503 (2001).
2. Weng C, Chan, et al. J. Med. Chem., 47, 4633 (2004).
3. G. Y. Ji, et al. J. Bacteriology, 187, 3139 (2005).
4. M. Otto, FEBS Lett., 424, 89 (1998).
5. P. Mayville, et al. Proc. Natl. Acad. Sci. USA 96, 1218 (1999).

About AnaSpec

AnaSpec is a leading provider of integrated proteomics solutions to the world’s largest biotech, pharmaceutical, and academic research institutions. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and antibodies.

AnaSpec recently joined forces with Eurogentec to provide an even broader spectrum of products and services to serve the worldwide life science community.

For more information visit

About Eurogentec

Eurogentec is a leading global supplier of innovative reagents, kits, specialty products and custom services to scientists in the life science, biotechnology, pharmaceutical and diagnostic markets. Eurogentec provides a wide range of expertize in small- and large-scale DNA, RNA, PCR and qPCR kits, peptide synthesis and antibody supply for research applications. Our ISO13485:2003-certified manufacturing facilities in Belgium provides a wide range of high value oligonucleotide-based components for diagnostic and therapeutic applications. Eurogentec’s Belgium manufacturing facility is complemented by additional production facilities in North America and Japan. Eurogentec is also an experienced Contract Manufacturing Organization (CMO) for Biopharmaceuticals, operating a full-service, state-of-the-art GMP facility in Belgium.

Eurogentec is a privately held company headquartered in Liège, Belgium, with subsidiaries in North America, France, Germany, the UK, the Netherlands and Switzerland and has additional production facilities in North America, Japan and Singapore. Eurogentec employs 400+ people globally.

For more information visit

Ping Yang
Marketing Speialist
34801 Campus Drive
Fremont, CA 94555
1-800-452-5530 (Toll free)
1-510-791-9560 (Tel)
1-510-791-9572 (Fax)
Back to top
View user's profile Send private message Send e-mail Visit poster's website
Display posts from previous:   
Post new topic   Reply to topic    Press Release Forum [] Forum Index -> Biotech Press Releases All times are GMT - 4 Hours
Page 1 of 1

Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum

Submit Press Release (Free)Submit Press Release


Editor's pick: